Management of Chronic Hepatitis C: Consensus Guidelines

Since the last consensus conference on the management of chronic viral hepatitis, a number of studies looking at modifications of the standard course of treatment have been published. These changes have been sufficiently substantive to warrant review to determine whether any changes in the recommend...

Full description

Saved in:
Bibliographic Details
Main Authors: Morris Sherman, Stephen Shafran, Kelly Burak, Karen Doucette, Winnie Wong, Nigel Girgrah, Eric Yoshida, Eberhard Renner, Philip Wong, Marc Deschênes
Format: Article
Language:English
Published: Wiley 2007-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2007/138245
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849695650934947840
author Morris Sherman
Stephen Shafran
Kelly Burak
Karen Doucette
Winnie Wong
Nigel Girgrah
Eric Yoshida
Eberhard Renner
Philip Wong
Marc Deschênes
author_facet Morris Sherman
Stephen Shafran
Kelly Burak
Karen Doucette
Winnie Wong
Nigel Girgrah
Eric Yoshida
Eberhard Renner
Philip Wong
Marc Deschênes
author_sort Morris Sherman
collection DOAJ
description Since the last consensus conference on the management of chronic viral hepatitis, a number of studies looking at modifications of the standard course of treatment have been published. These changes have been sufficiently substantive to warrant review to determine whether any changes in the recommended treatment algorithms are needed. A consensus development conference was held in January 2007, and the present document highlights the results of the presentations and discussion about these issues. It reviews the epidemiology of hepatitis C in Canada, treatment of acute hepatitis C and new algorithms in chronic hepatitis C, including retreatment of previous treatment failures. In addition, sections on management of hepatitis C in special populations have been updated. There is also a section on the use of hematopoietic growth factors to help manage patients on therapy. The document should be read in conjunction with the previous document to identify changes. Some recommendations made in the previous document remain and are not discussed here.
format Article
id doaj-art-d50c8a52bd0e4a6c9973d98270f9968e
institution DOAJ
issn 0835-7900
language English
publishDate 2007-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-d50c8a52bd0e4a6c9973d98270f9968e2025-08-20T03:19:42ZengWileyCanadian Journal of Gastroenterology0835-79002007-01-0121Suppl C25C34C10.1155/2007/138245Management of Chronic Hepatitis C: Consensus GuidelinesMorris Sherman0Stephen Shafran1Kelly Burak2Karen Doucette3Winnie Wong4Nigel Girgrah5Eric Yoshida6Eberhard Renner7Philip Wong8Marc Deschênes9Department of Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Medicine, University of Alberta, Edmonton, CanadaDepartment of Medicine, University of Calgary, Calgary, Alberta, CanadaDepartment of Medicine, University of Alberta, Edmonton, CanadaDepartment of Medicine, University of Alberta, Edmonton, CanadaDepartment of Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaDepartment of Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaDepartment of Medicine, McGill University, Montreal, Quebec, CanadaDepartment of Medicine, McGill University, Montreal, Quebec, CanadaSince the last consensus conference on the management of chronic viral hepatitis, a number of studies looking at modifications of the standard course of treatment have been published. These changes have been sufficiently substantive to warrant review to determine whether any changes in the recommended treatment algorithms are needed. A consensus development conference was held in January 2007, and the present document highlights the results of the presentations and discussion about these issues. It reviews the epidemiology of hepatitis C in Canada, treatment of acute hepatitis C and new algorithms in chronic hepatitis C, including retreatment of previous treatment failures. In addition, sections on management of hepatitis C in special populations have been updated. There is also a section on the use of hematopoietic growth factors to help manage patients on therapy. The document should be read in conjunction with the previous document to identify changes. Some recommendations made in the previous document remain and are not discussed here.http://dx.doi.org/10.1155/2007/138245
spellingShingle Morris Sherman
Stephen Shafran
Kelly Burak
Karen Doucette
Winnie Wong
Nigel Girgrah
Eric Yoshida
Eberhard Renner
Philip Wong
Marc Deschênes
Management of Chronic Hepatitis C: Consensus Guidelines
Canadian Journal of Gastroenterology
title Management of Chronic Hepatitis C: Consensus Guidelines
title_full Management of Chronic Hepatitis C: Consensus Guidelines
title_fullStr Management of Chronic Hepatitis C: Consensus Guidelines
title_full_unstemmed Management of Chronic Hepatitis C: Consensus Guidelines
title_short Management of Chronic Hepatitis C: Consensus Guidelines
title_sort management of chronic hepatitis c consensus guidelines
url http://dx.doi.org/10.1155/2007/138245
work_keys_str_mv AT morrissherman managementofchronichepatitiscconsensusguidelines
AT stephenshafran managementofchronichepatitiscconsensusguidelines
AT kellyburak managementofchronichepatitiscconsensusguidelines
AT karendoucette managementofchronichepatitiscconsensusguidelines
AT winniewong managementofchronichepatitiscconsensusguidelines
AT nigelgirgrah managementofchronichepatitiscconsensusguidelines
AT ericyoshida managementofchronichepatitiscconsensusguidelines
AT eberhardrenner managementofchronichepatitiscconsensusguidelines
AT philipwong managementofchronichepatitiscconsensusguidelines
AT marcdeschenes managementofchronichepatitiscconsensusguidelines